These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3164609)

  • 21. Degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human leukemic myeloblasts and lymphoblasts.
    Jamieson GP; Finch LR; Snook M; Wiley JS
    Cancer Res; 1987 Jun; 47(12):3130-5. PubMed ID: 3472653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ
    Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A common basis for inhibition of nucleoside transport by dipyridamole and nitrobenzylthioinosine?
    Paterson AR; Lau EY; Dahlig E; Cass CE
    Mol Pharmacol; 1980 Jul; 18(1):40-4. PubMed ID: 7412763
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate.
    Liliemark JO; Plunkett W
    Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The enhancement of the frequency of resistance to N-phosphonoacetyl-L-aspartate and methotrexate by 1-beta-D-arabinofuranosylcytosine: the effect of dipyridamole.
    Goz B; Jeffs L
    J Pharmacol Exp Ther; 1994 Aug; 270(2):480-4. PubMed ID: 8071840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine.
    Plagemann PG; Wohlhueter RM
    Biochim Biophys Acta; 1984 Jun; 773(1):39-52. PubMed ID: 6733097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of cytarabine uptake and toxicity by dipyridamole.
    King ME; Naporn A; Young B; Howell SB
    Cancer Treat Rep; 1984 Feb; 68(2):361-6. PubMed ID: 6697325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of proliferation in cultures of Chinook salmon embryo cells by interactions between inosine and bovine sera.
    Ganassin RC; Tran QH; Rabgey TF; Bols NC
    J Cell Physiol; 1994 Sep; 160(3):409-16. PubMed ID: 8077278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transport and metabolism of 1-beta-D-arabinofuranosylcytosine in human ovarian adenocarcinoma cells.
    Jamieson GP; Snook MB; Bradley TR; Bertoncello I; Wiley JS
    Cancer Res; 1989 Jan; 49(2):309-13. PubMed ID: 2910450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of nucleoside transport during leukemic cell differentiation.
    Takimoto T; Kitoh T; Tanizawa A; Akiyama Y; Kiriyama Y; Kubota M; Mikawa H
    Adv Exp Med Biol; 1989; 253B():517-23. PubMed ID: 2610141
    [No Abstract]   [Full Text] [Related]  

  • 31. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD
    Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new sensitive method for determination of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate content in human materials in vivo.
    Yamauchi T; Ueda T; Nakamura T
    Cancer Res; 1996 Apr; 56(8):1800-4. PubMed ID: 8620496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells.
    Momparler RL; Onetto-Pothier N; Bouffard DY; Momparler LF
    Cancer Chemother Pharmacol; 1990; 27(2):141-6. PubMed ID: 2249330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism and toxicity of electroporated 1-beta-D-arabinofuranosylcytosine triphosphate in a human leukemia cell line.
    Kubota M; Yorifuji T; Hashimoto H; Shimizu T; Mikawa H
    Jpn J Cancer Res; 1990 Dec; 81(12):1314-9. PubMed ID: 2126001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitrobenzylthioinosine-sensitive and -resistant nucleoside transport in normal and transformed rat cells.
    Plagemann PG; Wohlhueter RM
    Biochim Biophys Acta; 1985 Jun; 816(2):387-95. PubMed ID: 4005249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937.
    Horber DH; Schott H; Schwendener RA
    Cancer Chemother Pharmacol; 1995; 36(6):483-92. PubMed ID: 7554040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W; Hug V; Keating MJ; Chubb S
    Cancer Res; 1980 Mar; 40(3):588-91. PubMed ID: 6937239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
    Clarke ML; Damaraju VL; Zhang J; Mowles D; Tackaberry T; Lang T; Smith KM; Young JD; Tomkinson B; Cass CE
    Mol Pharmacol; 2006 Jul; 70(1):303-10. PubMed ID: 16617163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
    Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.